Share on

Latin America Solid Tumor Market Research Report – Segmented By Disease, Drugs and Country (Brazil, Argentina, Chile, Mexico and Rest of Latin America) - Industry Analysis, Size, Share, Growth, Trends and Forecast (2022 to 2027)

Published: March, 2023
ID: 6340
Pages: 145
Formats: report pdf report excel report power bi report ppt

Latin America Solid Tumor Market Size (2022 to 2027)

The Solid Tumor Market in Latin America is predicted to grow at a prominent CAGR during the forecast period.

Factors such as the high increase in the aging population and deep-rooted healthcare infrastructure drive market growth. Around 18.1 million novel cancer cases were registered in 2018, and it is also estimated that 1 in 6 women and 1 in 5 men are likely to be affected with cancer. The rise in the investments made by the key market players and many public and private organizations making funds for R & D activities, which is predicted to favor the growth rate of the market.

High costs associated with the treatment procedures is restraining market growth. Furthermore, the complications related to the treatment, such as skin reactions (allergies, redness, anemia, and hair loss), may hinder the solid tumor market growth.

This research report on the Latin America Solid Tumor Market has been segmented and sub-segmented into the following categories:

By Disease:

  • Breast cancer     
  • Lung cancer      
  • Colorectal cancer
  • Prostate cancer
  • Cervical cancer
  • Others    

By Drugs:

  • Carboplatin       
  • Cisplatin  
  • Gemcitabine      
  • Paclitaxel
  • Doxorubicin      
  • Bevacizumab     
  • Erlotinib  
  • Sunitinib  
  • Everolimus      
  • Docetaxel       
  • Abiraterone     
  • Abiraterone acetate     
  • Cabazitaxel

By Country:

  • Brazil
  • Argentina
  • Chile
  • Mexico
  • Rest of Latin America

Regional Analysis:

The solid tumor market in Latin America is anticipated to have a steady CAGR growth during the assessment period. The market growth in this region is attributed to a rise in cancer cases and swelling occurrences of a few solid tumors cases. Moreover, the government's number of initiatives in accepting the growing demand for the solid tumor market impels market growth during the analysis period. Favorable reimbursement schemes are augmenting market growth. Brazil is set to dominate the region's solid tumor market because of the growing awareness about cancer and its treatment, improving healthcare infrastructure, and rising medical tourism. Growing outgoing towards healthcare and increasing discretionary expenses are likely to boost the region's growth during the historical period.

Key players leading the Latin American Solid Tumor Market profiled in this report are Baxter International, Inc., Bristol-Myers Squibb Company, F. Hoffmann-La Roche Ltd., Eli Lilly and Company, AstraZeneca plc, Abbott Laboratories, Inc., Amgen, Inc., Biogen Idec, Inc., Boehringer Ingelheim GmbH, Johnson & Johnson, GlaxoSmithKline plc, Kyowa Hakko Kirin Co., Ltd., and Sanofi among others.

Please wait. . . . Your request is being processed

Related Reports

Access the study in MULTIPLE FORMATS
Purchase options starting from $ 2000

Didn’t find what you’re looking for?
TALK TO OUR ANALYST TEAM

Need something within your budget?
NO WORRIES! WE GOT YOU COVERED!

REACH OUT TO US

Call us on: +1 888 702 9696 (U.S Toll Free)

Write to us: [email protected]

Click for Request Sample